We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-17.1%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
-$1.36B
(-19%)
Cap. Flow
-$72.7M
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
17.58%
Holding
1,139
New
165
Increased
376
Reduced
380
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$58.3M |
| 2 |
CELG
Celgene Corp
CELG
|
+$27.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$23.3M |
| 4 |
TJX Companies
TJX
|
+$23.1M |
| 5 |
Synopsys
SNPS
|
+$19.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dell
DELL
|
+$45.2M |
| 2 |
Rockwell Automation
ROK
|
+$25.3M |
| 3 |
Accenture
ACN
|
+$24M |
| 4 |
Visteon
VC
|
+$23.4M |
| 5 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.85% |
| 2 | Financials | 17.71% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Healthcare | 11.49% |
| 5 | Industrials | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
651
Accenture
ACN
$89.9B
| $770K | 0.01% |
5,463
-151,879
| -97% | -$24M |
|
652
Viatris
VTRS
$20.1B
| $769K | 0.01% |
+28,070
| New | +$909K |
|
653
Innospec
IOSP
$2.09B
| $766K | 0.01% |
12,410
| – | – |
|
654
Metropolitan Bank Holding Corp
MCB
$1.13B
| $766K | 0.01% |
24,843
-5,140
| -17% | -$189K |
|
655
Marten Transport
MRTN
$1.33B
| $760K | 0.01% |
+70,379
| New | +$881K |
|
656
Eastman Chemical
EMN
$7.8B
| $756K | 0.01% |
+10,340
| New | +$824K |
|
657
Talos Energy
TALO
$2.49B
| $748K | 0.01% |
+45,834
| New | +$1.08M |
|
|
DENN
658
DELISTED
Denny's
DENN
| $747K | 0.01% |
46,100
-5,300
| -10% | -$83.4K |
|
659
Flotek Industries
FTK
$935M
| $747K | 0.01% |
+114,145
| New | +$1.15M |
|
|
BELFB
660
Bel Fuse Inc Class B
BELFB
$3.88B
| $746K | 0.01% |
40,504
-3,173
| -7% | -$71.7K |
|
|
AQ
661
DELISTED
Aquantia Corp. Common Stock
AQ
| $743K | 0.01% |
84,715
+71,625
| +547% | +$726K |
|
|
NCI
662
DELISTED
Navigant Consulting, Inc.
NCI
| $735K | 0.01% |
+30,570
| New | +$699K |
|
663
Qorvo
QRVO
$7.63B
| $733K | 0.01% |
+12,070
| New | +$812K |
|
|
PPLI
664
People Inc
PPLI
$3.1B
| $730K | 0.01% |
22,326
-14,828
| -40% | -$498K |
|
665
Selective Insurance
SIGI
$5.74B
| $729K | 0.01% |
11,968
| – | – |
|
666
Haemonetics
HAE
$3.58B
| $728K | 0.01% |
7,281
-920
| -11% | -$96.6K |
|
|
JWN
667
DELISTED
Nordstrom
JWN
| $726K | 0.01% |
15,570
+7,720
| +98% | +$436K |
|
668
Merck
MRK
$324B
| $726K | 0.01% |
9,956
-107,694
| -92% | -$7.6M |
|
669
VF Corp
VFC
$6.68B
| $721K | 0.01% |
10,726
-88,252
| -89% | -$6.75M |
|
670
STAAR Surgical
STAA
$1.16B
| $718K | 0.01% |
22,502
-1,490
| -6% | -$58.1K |
|
|
ALEX
671
DELISTED
Alexander & Baldwin
ALEX
| $712K | 0.01% |
38,731
| – | – |
|
|
ELVT
672
DELISTED
Elevate Credit, Inc.
ELVT
| $712K | 0.01% |
158,937
+53,884
| +51% | +$283K |
|
673
U-Haul Holding Co
UHAL
$14B
| $707K | 0.01% |
+21,550
| New | +$728K |
|
674
Amphastar Pharmaceuticals
AMPH
$825M
| $703K | 0.01% |
35,325
| – | – |
|
675
James River Group Holdings
JRVR
$218M
| $691K | 0.01% |
18,922
-2,690
| -12% | -$102K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2018 Portfolio in Review
As of Q4 2018, Jacobs Levy Equity Management held 1,139 positions worth $5.69B, down 19% from $7.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management's Q4 2018 filing shows 165 new, 376 increased, 380 reduced and 175 closed positions. Its largest new stake was Starbucks: 930,980 shares worth $60M. The largest sale was Dell, an estimated $45.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q4 2018 buy was Starbucks: 930,980 shares worth $60M.
- Jacobs Levy Equity Management added most to Celgene Corp in Q4 2018, an estimated $27.6M increase.
- Jacobs Levy Equity Management's biggest Q4 2018 reduction was Accenture, cutting an estimated $24M.
- Jacobs Levy Equity Management fully exited Dell in Q4 2018, selling an estimated $45.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $5.69B portfolio in Q4 2018.
- Jacobs Levy Equity Management opened 165 new positions and closed 175 in Q4 2018.
- Jacobs Levy Equity Management's portfolio value fell 19% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2018, filed 14 Feb 2019.